Jing L. Marantz

Insider Reports History

Entity
Individual
Location
C/O Krystal Biotech, Inc., 2100 Wharton Street, Suite 701, Pittsburgh, Pennsylvania
Signature
/s/ Ilan Katz, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jing L. Marantz:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Krystal Biotech, Inc. Chief Business Officer Stock Option (Right to Buy) 205 K $16.8 M $81.91 Jan 31, 2022 Direct
Scholar Rock Holding Corp CHIEF MEDICAL OFFICER Common Stock 72.9 K $1.16 M $15.93 Feb 12, 2024 Direct
Arcturus Therapeutics Holdings Inc. Director Common Stock 3.13 K $100 K $32.03 Jun 14, 2024 Direct
Arcturus Therapeutics Holdings Inc. Director Deferred Stock Units 0 $0 $32.03 Jun 14, 2024 Direct
Scholar Rock Holding Corp CHIEF MEDICAL OFFICER Stock Option (Right to Buy) 97.1 K Feb 12, 2024 Direct
Arcturus Therapeutics Holdings Inc. Director Stock option (right to buy) 15 K Jun 14, 2024 Direct

Insider Reports Filed by Jing L. Marantz

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ARCT Arcturus Therapeutics Holdings Inc. Jun 14, 2024 3 $0 4 Jun 18, 2024 Director
SRRK Scholar Rock Holding Corp Feb 12, 2024 2 $0 4 Feb 13, 2024 CHIEF MEDICAL OFFICER
ARCT Arcturus Therapeutics Holdings Inc. Aug 1, 2023 2 $0 4 Aug 3, 2023 Director
SRRK Scholar Rock Holding Corp Nov 14, 2022 1 $0 4 Nov 15, 2022 Chief Medical Officer
SRRK Scholar Rock Holding Corp Nov 9, 2022 0 $0 3 Nov 15, 2022 Chief Medical Officer
ARCT Arcturus Therapeutics Holdings Inc. Jun 23, 2022 1 $0 4 Jun 27, 2022 Director
KRYS Krystal Biotech, Inc. Jan 31, 2022 1 $0 4 Jan 31, 2022 Chief Business Officer
ARCT Arcturus Therapeutics Holdings Inc. Dec 7, 2021 2 $0 4 Dec 9, 2021 Director
ARCT Arcturus Therapeutics Holdings Inc. Dec 7, 2021 0 $0 3 Dec 9, 2021 Director
KRYS Krystal Biotech, Inc. Jun 30, 2021 1 $0 4 Jul 2, 2021 Director